The Effect of Vaccination Against Human Papillomavirus on Fecundability
- 7 September 2017
- journal article
- research article
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 31 (6) , 531-536
Abstract
Background: The human papillomavirus (HPV) vaccine was developed to prevent infection with strains of HPV that cause cervical cancer. While HPV infection has been associated with reduced semen quality and lower pregnancy rates in some studies, no studies have examined the relationship between HPV vaccination and fecundability. We hypothesize that HPV prevention via vaccination will protect fecundity.Methods: We analysed data from Pregnancy Study Online (PRESTO), a preconception cohort of North American pregnancy planners. Between 2013 and 2017, we followed 3483 female pregnancy planners and 1022 of their male partners for 12 months or until reported pregnancy, whichever came first. At baseline, participants reported whether they had been vaccinated against HPV and their age at vaccination. We estimated fecundability ratios (FR) and 95% confidence intervals (CI) using proportional probabilities models adjusted for sociodemographics, smoking, and abnormal Pap test before HPV vaccination (females only).Results: HPV vaccination was more prevalent among females (33.9%) than males (5.2%). There was little overall association between female vaccination (FR 0.98, 95% CI 0.90, 1.08) or male vaccination (FR 1.07, 95% CI 0.79, 1.46) and fecundability. Among females with a history of sexually transmitted infections or pelvic inflammatory disease (i.e. a group at high risk of exposure to HPV infection), those vaccinated against HPV had higher fecundability than those not vaccinated (FR 1.35, 95% CI 0.99, 1.86).Conclusion: Although HPV vaccination had little effect on fecundability overall, HPV vaccination was positively associated with fecundability among women with a history of sexually transmitted infections.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health (R01‐HD086742, R21‐HD072326, T32‐HD052458, R03‐HD094117)
- Kræftens Bekæmpelse (R167‐A110336‐17‐S2)
This publication has 16 references indexed in Scilit:
- Spontaneous fertility and in vitro fertilization outcome: new evidence of human papillomavirus sperm infectionFertility and Sterility, 2016
- Human Papillomavirus Positivity in Women Undergoing Intrauterine Insemination Has a Negative Effect on Pregnancy RatesGynecologic and Obstetric Investigation, 2015
- Association, prevalence, and clearance of human papillomavirus and antisperm antibodies in infected semen samples from infertile patientsFertility and Sterility, 2013
- "Toward a Clearer Definition of Confounding" Revisited With Directed Acyclic GraphsAmerican Journal of Epidemiology, 2012
- Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccinationBMC Public Health, 2012
- Pregnancy incidence and outcome among patients with cervical intraepithelial neoplasia: a retrospective cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in ratsReproductive Toxicology, 2011
- Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague‐Dawley ratsBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2010
- Sociocultural Issues in the Introduction of Human Papillomavirus Vaccine in Low-Resource SettingsArchives of Pediatrics & Adolescent Medicine, 2009
- Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague‐Dawley ratsBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2008